A 2020 study[149] treated AML cells with DNR, Ara‐C, etoposide (Eto), and fludarabine (Flu) and compared CRT and HSP70/90 translocation, HMGB1, and ATP release (Figure 8). The gene discussed is CALR; the disease is acute myeloid leukemia.